Contributed by Shing-Tung Yau; received January 29, 2024; accepted July 19, 2024; reviewed by Stephan Huckemann and Jingyi Jessica Li Single-cell RNA sequencing (scRNA-seq) analysis, crucial for ...
Department of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, Florida 33458, United States Department of Chemistry, The Herbert Wertheim UF Scripps Institute for Biomedical ...
Tempus AI Inc (NASDAQ:TEM) shares are trading higher Monday morning after the company announced it has received U.S. Food and Drug Administration 510(k) clearance for its RNA-based Tempus xR IVD ...
KYOTO & FUJISAWA, Japan--(BUSINESS WIRE)--xFOREST Therapeutics Co., Ltd. (“xFOREST”) and Axcelead Drug Discovery Partners, Inc. (“Axcelead DDP”) today announced the launch of a joint research ...
Thanks to a partnership with Ionis Pharmaceuticals, Biogen has a long history with antisense oligonucleotides, which can modify the production of proteins in the body. The two companies developed the ...
Contributed by Bruce E. Tabashnik; received July 12, 2025; accepted August 17, 2025; reviewed by William D. Hutchison and Christian H. Krupke ...
Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than good. A new study from University of California San Diego and Yale ...
Human-based genetic editing systems — as opposed to bacteria-based editing systems like CRISPR — have less potential for issues. Photo credit: iStock Genetic editing holds promise to treat incurable ...
Aging and Cardiovascular Discovery Center (C.G., M.C., V.M., C.B., D.J., C.T., Z.C., M.T., A.K.R., V.N.S.G., R.K.), Lewis Katz School of Medicine, Temple University ...
Department of Chemistry, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, 130 Scripps Way, Jupiter, Florida 33458, United States Department of Chemistry, The Scripps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback